To evaluate the presented influences of resveratrol on malignant plasticity in CRC cells via p53 pathway, the controversy existing in the literature about resveratrol’s Sirt-1/p53 modulation needs to be discussed. The gene discussed is TP53; the disease is colorectal carcinoma.